MedTrace Logo

ItAlian ReGistry Of pNeumoniA in immUnocompromised paTients (ARGONAUT)

NCT06755814 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1298

Last updated 2025-11-18

No results posted yet for this study

Summary

This multicentric, prospective study aims at:

evaluating the prevalence, etiology, characteristics, and 1one-year outcomes of immunocompromised patients hospitalized for Community-Acquired Pneumonia (CAP); conducting biochemical, microbiological and genetic analysis on collected samples.

Conditions

  • Community Acquired Pneumonia (CAP)

Sponsors & Collaborators

  • Societa Italiana di Pneumologia

    lead OTHER

Principal Investigators

  • Francesco B.A. Blasi, MD · Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-11
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06755814 on ClinicalTrials.gov